Hong Kong, July 11, 2024 — The "LPF Fund Sharing Session: Field Inspection - Visit to the Biotechnology Testing Center" event, organized by the Family Office Fintech Association (FOFA), was successfully held today. The event attracted many professional investors, biotechnology and medical experts, and financial and investment institutions, aiming to showcase quality investment opportunities in the biotechnology sector.
Strategic Investment Directions of the Fund
During the event, Fund General Partner Archie Fong stated that the fund's current strategic investments are primarily focused on the following three directions:
AI Pathology Testing: Utilizing artificial intelligence technology to improve the accuracy and efficiency of pathology testing.
Advanced Blood Testing Technology: Early detection of Alzheimer's symptoms to enhance prevention and treatment outcomes.
Early Cancer Detection through Genetic Testing: Achieving early diagnosis of cancer through genetic testing, thus improving treatment success rates.
Mr. Fong also mentioned that these research results will eventually be converted into market profit, with plans to list on the NASDAQ in the United States.
Demand for Financial Technology Talent in Hong Kong
Fund General Partner Dr. Colin Lee emphasized the need for more talent and financing platforms that integrate finance and technology in Hong Kong. He stated that the support for the fund and project development is a vote of confidence in Hong Kong's investment environment and will help elevate Hong Kong's status in the global biotechnology market.
Participant Backgrounds
The participants of this event included:
Professional investors
International family offices
Licensed financial institutions already invested in other medical fields
Immigration companies
Bank representatives
Medical technology companies
These participants discussed the fund's investment strategies in medical artificial intelligence, medical technology, equity initiatives, and medical services, and gained a deeper understanding of one of the fund's project segments.
Event Summary
This event not only showcased the fund's investment strategies and future plans but also provided participants with a platform to gain firsthand insights into biotechnology investment opportunities. With the rapid development of artificial intelligence and biotechnology, these investment directions are expected to yield significant market returns.
For more information about this event, please visit the FOFA "Association Events" website or contact the FOFA team.
FOFA Contact Information:
Phone: 852-6200-2777
Email: info@fofahk.com
Comments